Ester Lopez
45 Poplar Road
Parkville, VIC 3052, Australia
Parkville, VIC 3052, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Antibody glycosylation correlates with disease progression in SIV-Mycobacterium tuberculosis coinfected cynomolgus macaques.
Journal: Clinical & translational immunology
Published: August 22, 2023
Potent pan huACE2-dependent sarbecovirus neutralizing monoclonal antibodies isolated from a BNT162b2-vaccinated SARS survivor.
Journal: Science advances
Published: July 26, 2023
Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants.
Journal: Medical microbiology and immunology
Published: April 22, 2023
Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2.
Journal: Frontiers in immunology
Published: December 13, 2022
Biparatopic nanobodies targeting the receptor binding domain efficiently neutralize SARS-CoV-2.
Journal: iScience
Published: March 24, 2022
Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2.
Journal: Frontiers in immunology
Published: March 04, 2022
Heterologous SARS-CoV-2 IgA neutralising antibody responses in convalescent plasma.
Journal: Clinical & translational immunology
Published: February 02, 2022
A Quantitative Approach to Unravel the Role of Host Genetics in IgG-FcγR Complex Formation After Vaccination.
Journal: Frontiers in immunology
Published: November 22, 2021
Tear antibodies to SARS-CoV-2: implications for transmission.
Journal: Clinical & translational immunology
Published: July 22, 2021
Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay.
Journal: JCI insight
Published: July 12, 2021
Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain.
Journal: Cell reports
Published: June 03, 2021
Last Updated: 09/26/2026